MoodSpark (Telememory Holding Corp) Acquires Dthera Sciences
May 11, 2022
Telememory Holding Corp (dba MoodSpark) has acquired Dthera Sciences, a San Diego–based pioneer in digital therapeutics, bringing Dthera’s FDA Breakthrough-designated device, patents, and clinical pilot research under the MoodSpark platform. The deal expands MoodSpark’s intellectual property and clinical capabilities in digital reminiscence therapy and cognitive behavioral interventions for seniors with Alzheimer’s and dementia, accelerating its offering for senior and veteran populations.
- Buyers
- MoodSpark (Telememory Holding Corp)
- Targets
- Dthera Sciences
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Natus Sensory Acquires TheraB Medical
February 11, 2026
Medical Devices
Natus Sensory has acquired TheraB Medical, a developer of the SnugLit wearable phototherapy swaddle for neonatal jaundice, following the product's FDA 510(k) clearance in January 2026. The acquisition expands Natus Sensory's newborn care portfolio by adding a portable, family-centered phototherapy option intended to broaden treatment settings and global access.
-
MapHabit, Inc. Acquires Brain Stim, LLC
February 25, 2021
Healthcare Services
MapHabit, Inc. acquired Brain Stim, LLC, a provider of daily cognitive engagement content for individuals with mid-stage dementia. The deal (completed in early January 2021) integrates Brain Stim’s 365-day cognitive programming into MapHabit’s patented visual mapping and scheduling platform to expand its dementia care coordination and engagement capabilities.
-
Discovery Behavioral Health Acquires Anew Era TMS & Psychiatry
July 18, 2022
Healthcare Services
Discovery Behavioral Health acquired Anew Era TMS & Psychiatry, adding 12 outpatient TMS and psychiatry centers (six in California and six in Texas) to its network. The deal expands Discovery's outpatient psychiatry and neuromodulation capabilities as part of its Discovery MD professional psychiatric services division.
-
SonderMind Acquires Mindstrong's Technology
March 22, 2023
Healthcare Services
SonderMind acquired the technology assets and select technology team members of Mindstrong as Mindstrong wound down operations. The deal adds Mindstrong’s digital measurement, data science, and virtual care capabilities to SonderMind to enable more personalized, measurement-based mental health care and enhanced support for patients with serious mental illness.
-
Braxia Scientific Acquires KetaMD to Expand U.S. Telemedicine Ketamine Services
August 3, 2022
Healthcare Services
Braxia Scientific Corp. acquired 100% of KetaMD, a U.S.-based telemedicine platform offering at‑home, medically supervised ketamine treatments, in a share purchase completed in August 2022. The acquisition gives Braxia digital telehealth capabilities to complement its clinics and R&D, with KetaMD continuing to operate under its own brand and plans to expand beyond Florida into other U.S. states.
-
Biogen Acquires Alcyone Therapeutics
September 19, 2025
Medical Devices
Biogen has acquired Alcyone Therapeutics to obtain the ThecaFlex DRx intrathecal drug‑delivery system, integrating Alcyone employees into Biogen’s product delivery solutions team. Alcyone will receive $85 million upfront plus contingent milestone payments; Biogen will handle development, commercialization and manufacturing of ThecaFlex DRx while Alcyone’s remaining therapeutic assets are being divested into Neela Therapeutics.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.